IDXX

IDEXX Laboratories, Inc. Common Stock Nasdaq Global Select
$608.02
Open: $601.05 High: $608.83 Low: $592.4 Close: $608.83
Range: 2021-06-19 - 2021-06-21
Volume: 73,707
Market: Open
Powered by Finage Stock APIDelayed data
IDXX
IDEXX Laboratories, Inc. Common Stock One IDEXX Drive Westbrook ME, 4092 http://www.idexx.com
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets.
  • CEO: Jonathan W. Ayers
  • Employees: 7,600
  • Sector: Healthcare
  • Industry: Medical Diagnostics & Research
IDXX News
Latest news about the IDXX
  • Thermo Fisher's (TMO) New Launch Boosts Preclinical Development

    Thermo Fisher's (TMO) enhanced Quick to Clinic solution provides balance of speed and quality to accelerate and advance DNA to Investigational New Drug in as less as 13 months.

    View More →
  • Bruker (BRKR) Updates 2021 Outlook, Issues Medium-Term View

    Bruker (BRKR) updates 2021 financial guidance encouraged by solid business growth and high-growth opportunities.

    View More →
  • Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now

    Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and bullish 2021 outlook.

    View More →
  • Medtronic (MDT) Progresses in SCS With FDA Nod for Vanta

    Vanta utilizes Medtronic's (MDT) proprietary AdaptiveStim technology for personalized pain relief.

    View More →
  • Idexx Stock Clears Key Benchmark Amid Strong Profit, Sales Growth; Expands Via Cloud Software Buyout

    On Friday, the Relative Strength (RS) Rating for Idexx Laboratories rose into a new category, climbing to 82, up from 79 the day before. The 82 RS Rating means that Idexx stock has outperformed 82% of all stocks over the past year. Confirming its outstanding growth, Idexx stock has a 98 EPS Rating and a 98 Composite Rating.

    View More →
  • Henry Schein (HSIC) Enhances Dental Practices With New Deal

    Henry Schein's (HSIC) acquisition of majority stake in eAssist will enable it to offer best quality solutions to help dental practices operate efficiently and profitably.

    View More →
  • Hologic (HOLX) Acessa Procedure Now Covered by Cigna Insurance

    Hologic's (HOLX) Acessa procedure new coverage will further validate Laparoscopic Radiofrequency Ablation as a standard of care for uterine fibroids.

    View More →
  • CVS Health (CVS) Deploys Time-Delay Safes in Georgia Pharmacies

    CVS Health's (CVS) time-delay safes are anticipated to help reduce robbery incidents.

    View More →
  • Up 100% in a Year, Can This Animal Health Stock Keep Climbing?

    Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high?

    View More →
  • Medtronic (MDT) Progresses in Neuromodulation on New FDA Nod

    Medtronic's (MDT) SenSight claims to deliver patient-specific DBS therapy for the treatment of symptoms associated with Parkinson's, dystonia and essential tremor and medically refractory epilepsy.

    View More →
  • Abbott (ABT) Confirms Capacity to Support MCS Devices Demand

    Abbott's (ABT) HeartMate 3 heart pump can significantly enhance quality of life and reduce adverse events.

    View More →
  • Here's Why You Should Retain CVS Health (CVS) in Your Portfolio

    Investors are optimistic about CVS Health (CVS) on solid first-quarter performance and growth in digital health services.

    View More →
  • Idexx Laboratories (IDXX) Gains As Market Dips: What You Should Know

    Idexx Laboratories (IDXX) closed the most recent trading day at $560.35, moving +0.36% from the previous trading session.

    View More →
  • STERIS (STE) Expands Product Suite With New Acquisition

    STERIS' (STE) acquisition of Cantel Medical will complement and broaden the former's product and service offerings, global reach and customers.

    View More →
  • Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

    Is (IDXX) Outperforming Other Medical Stocks This Year?

    View More →
  • IDEXX (IDXX) Acquires ezyVet to Boost Practice Management Arm

    The latest acquisition adds to IDEXX's (IDXX) cloud-based practice information management system (PIMS) segment.

    View More →
  • Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

    Let's talk about the popular IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's shares saw a double-digit share...

    View More →
  • Why Is Idexx (IDXX) Up 3.3% Since Last Earnings Report?

    Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    View More →
  • Why IDEXX (IDXX) Could Be an Impressive Growth Stock

    If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX (IDXX).

    View More →
  • IDEXX Acquires ezyVet

    IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today the acquisition of ezyVet®, a fast-growing, innovative practice information management system (PIMS). With the acquisition, IDEXX further expands its world-class cloud software offerings that support customers with technology solutions that raise the standard of care for patients, improve practice efficiency, and enable more effective communication with pet owners.

    View More →